Novartis

Novartis

Metrics Value

Scope 2 Emissions

2014 = 968,172 tonnes

Scope 1 Emissions

2014 = 643,547 tonnes

Performance Score

2014 = B /A,A-,B,C,D,E

Environmental Fines (G4-EN29-a)

2015 = $ 139,671

Indirect greenhouse gas (GHG) emissions (Scope 2) (G4-EN16-a)

2015 = 819,900 tonnes CO2 equivalent

Hazardous Waste Recycled (G4-EN23-a)

2015 = 119,680 tonnes

Greenhouse Gas (GHG) emissions intensity ratio (G4-EN18-a)

2015 = 27 : 1

Non-hazardous Waste Recycled (G4-EN-23-a)

2015 = 62,250 tonnes

Fuel Consumption from Non-renewable sources (G4-EN3-a)

2015 = 16.9M Gigajoules

Fuel consumption from renewable sources (G4-EN3-b)

2015 = 150,040 Gigajoules

Combined Scope 1, 2 and 3 Intensity

2013 = 171.68

Non-Hazardous Waste (G4-EN23-a)

2015 = 83,000 tonnes

Total water discharge (G4-EN22-a)

2015 = 16.6M m3

Energy intensity (G4-EN5-a)

2015 = 145 : 1

Volatile Organic Compounds (VOC) emissions (G4-EN21-a)

2015 = 587.6 tonnes

Hazardous Waste Created (G4-EN23-a)

2015 = 176,000 tonnes

Reduction of greenhouse gas (GHG) emissions (G4-EN19-a)

2015 = 11,200 tonnes CO2 equivalent

Environmental non-monetary sanctions (G4-EN29-a)

2015 = 2

Reduction of Energy Consumption (G4-EN6-a)

2015 = -80,000 Gigajoules

Scope 1 and 2 Intensity

2013 = 25.9
+Wikipedia
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market cap and sales. Novartis manufactures such drugs as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include ciclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. In 1996, Ciba-Geigy merged with Sandoz, and the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity.